380 related articles for article (PubMed ID: 29468415)
1. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
Li Q; Zhao Q; Zhang C; Zhang P; Hu A; Zhang L; Schroder PM; Ma Y; Guo Z; Zhu X; He X
J Physiol Biochem; 2018 May; 74(2):247-260. PubMed ID: 29468415
[TBL] [Abstract][Full Text] [Related]
2. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
[TBL] [Abstract][Full Text] [Related]
4. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
Uriarte I; Latasa MU; Carotti S; Fernandez-Barrena MG; Garcia-Irigoyen O; Elizalde M; Urtasun R; Vespasiani-Gentilucci U; Morini S; de Mingo A; Mari M; Corrales FJ; Prieto J; Berasain C; Avila MA
Int J Cancer; 2015 May; 136(10):2469-75. PubMed ID: 25346390
[TBL] [Abstract][Full Text] [Related]
5. Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.
Yu Y; Shi X; Zheng Q; Wang X; Liu X; Tan M; Lv G; Zhang P; Martin RC; Li Y
Int J Biol Sci; 2021; 17(10):2576-2589. PubMed ID: 34326695
[No Abstract] [Full Text] [Related]
6. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice.
Padrissa-Altés S; Bachofner M; Bogorad RL; Pohlmeier L; Rossolini T; Böhm F; Liebisch G; Hellerbrand C; Koteliansky V; Speicher T; Werner S
Gut; 2015 Sep; 64(9):1444-53. PubMed ID: 25416068
[TBL] [Abstract][Full Text] [Related]
7. Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis.
Romain G; Tremblay S; Arena ET; Antunes LC; Covey S; Chow MT; Finlay BB; Menendez A
BMC Microbiol; 2013 Oct; 13():238. PubMed ID: 24165751
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice.
Kong B; Sun R; Huang M; Chow MD; Zhong XB; Xie W; Lee YH; Guo GL
Hepatology; 2018 Nov; 68(5):1961-1976. PubMed ID: 29672888
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
[TBL] [Abstract][Full Text] [Related]
11. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.
Alvarez-Sola G; Uriarte I; Latasa MU; Jimenez M; Barcena-Varela M; Santamaría E; Urtasun R; Rodriguez-Ortigosa C; Prieto J; Berraondo P; Fernandez-Barrena MG; Berasain C; Avila MA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1326-1334. PubMed ID: 28709961
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
[TBL] [Abstract][Full Text] [Related]
13. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
[TBL] [Abstract][Full Text] [Related]
14. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
15. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
[TBL] [Abstract][Full Text] [Related]
16. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.
Uriarte I; Fernandez-Barrena MG; Monte MJ; Latasa MU; Chang HC; Carotti S; Vespasiani-Gentilucci U; Morini S; Vicente E; Concepcion AR; Medina JF; Marin JJ; Berasain C; Prieto J; Avila MA
Gut; 2013 Jun; 62(6):899-910. PubMed ID: 23292666
[TBL] [Abstract][Full Text] [Related]
17. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
Shin DJ; Osborne TF
J Biol Chem; 2009 Apr; 284(17):11110-20. PubMed ID: 19237543
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.
Kong B; Huang J; Zhu Y; Li G; Williams J; Shen S; Aleksunes LM; Richardson JR; Apte U; Rudnick DA; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G893-902. PubMed ID: 24699334
[TBL] [Abstract][Full Text] [Related]
20. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.
Gutierrez A; Ratliff EP; Andres AM; Huang X; McKeehan WL; Davis RA
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):301-6. PubMed ID: 16284190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
